These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 32770635)

  • 1. Engineered Live Biotherapeutics: Progress and Challenges.
    Tan Y; Shen J; Si T; Ho CL; Li Y; Dai L
    Biotechnol J; 2020 Oct; 15(10):e2000155. PubMed ID: 32770635
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthetic Biology and Engineered Live Biotherapeutics: Toward Increasing System Complexity.
    Ozdemir T; Fedorec AJH; Danino T; Barnes CP
    Cell Syst; 2018 Jul; 7(1):5-16. PubMed ID: 30048620
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emerging strategies for engineering microbial communities.
    Tsoi R; Dai Z; You L
    Biotechnol Adv; 2019 Nov; 37(6):107372. PubMed ID: 30880142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Next generation probiotics: Engineering live biotherapeutics.
    Murali SK; Mansell TJ
    Biotechnol Adv; 2024; 72():108336. PubMed ID: 38432422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Engineered microbial consortia: strategies and applications.
    Duncker KE; Holmes ZA; You L
    Microb Cell Fact; 2021 Nov; 20(1):211. PubMed ID: 34784924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Engineering the human gut commensal Bacteroides thetaiotaomicron with synthetic biology.
    Lai Y; Hayashi N; Lu TK
    Curr Opin Chem Biol; 2022 Oct; 70():102178. PubMed ID: 35759819
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Engineered microbial systems for advanced drug delivery.
    Shen H; Aggarwal N; Wun KS; Lee YS; Hwang IY; Chang MW
    Adv Drug Deliv Rev; 2022 Aug; 187():114364. PubMed ID: 35654214
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthetic Biology Tools to Engineer Microbial Communities for Biotechnology.
    McCarty NS; Ledesma-Amaro R
    Trends Biotechnol; 2019 Feb; 37(2):181-197. PubMed ID: 30497870
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic engineering of human gut microbiome: Recent developments and future perspectives.
    Li P; Roos S; Luo H; Ji B; Nielsen J
    Metab Eng; 2023 Sep; 79():1-13. PubMed ID: 37364774
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Engineered Bacteria-Based Living Materials for Biotherapeutic Applications.
    Omer R; Mohsin MZ; Mohsin A; Mushtaq BS; Huang X; Guo M; Zhuang Y; Huang J
    Front Bioeng Biotechnol; 2022; 10():870675. PubMed ID: 35573236
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Artificial intelligence and synthetic biology approaches for human gut microbiome.
    Kumar P; Sinha R; Shukla P
    Crit Rev Food Sci Nutr; 2022; 62(8):2103-2121. PubMed ID: 33249867
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advances in synthetic biology toolboxes paving the way for mechanistic understanding and strain engineering of gut commensal Bacteroides spp. and Clostridium spp.
    Tan Y; Liang J; Lai M; Wan S; Luo X; Li F
    Biotechnol Adv; 2023 Dec; 69():108272. PubMed ID: 37844770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design of synthetic microbial consortia for gut microbiota modulation.
    Vázquez-Castellanos JF; Biclot A; Vrancken G; Huys GR; Raes J
    Curr Opin Pharmacol; 2019 Dec; 49():52-59. PubMed ID: 31430629
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Top-down and bottom-up microbiome engineering approaches to enable biomanufacturing from waste biomass.
    Lyu X; Nuhu M; Candry P; Wolfanger J; Betenbaugh M; Saldivar A; Zuniga C; Wang Y; Shrestha S
    J Ind Microbiol Biotechnol; 2024 Jan; 51():. PubMed ID: 39003244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthetic Biology Approaches to Engineer Probiotics and Members of the Human Microbiota for Biomedical Applications.
    Bober JR; Beisel CL; Nair NU
    Annu Rev Biomed Eng; 2018 Jun; 20():277-300. PubMed ID: 29528686
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biotechnological potential and applications of microbial consortia.
    Qian X; Chen L; Sui Y; Chen C; Zhang W; Zhou J; Dong W; Jiang M; Xin F; Ochsenreither K
    Biotechnol Adv; 2020; 40():107500. PubMed ID: 31862233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthetic microbial consortia: from systematic analysis to construction and applications.
    Song H; Ding MZ; Jia XQ; Ma Q; Yuan YJ
    Chem Soc Rev; 2014; 43(20):6954-81. PubMed ID: 25017039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Engineered probiotics as live biotherapeutics for diagnosis and treatment of human diseases.
    Meng J; Liu S; Wu X
    Crit Rev Microbiol; 2024 May; 50(3):300-314. PubMed ID: 36946080
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reprint of Design of synthetic microbial communities for biotechnological production processes.
    Jagmann N; Philipp B
    J Biotechnol; 2014 Dec; 192 Pt B():293-301. PubMed ID: 25444870
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systems and synthetic biology-driven engineering of live bacterial therapeutics.
    Kim K; Kang M; Cho BK
    Front Bioeng Biotechnol; 2023; 11():1267378. PubMed ID: 37929193
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.